DNA-PK inhibitor peposertib enhances p53-dependent cytotoxicity of DNA double-strand break inducing therapy in acute leukemia
Abstract Peposertib (M3814) is a potent and selective DNA-PK inhibitor in early clinical development. It effectively blocks non-homologous end-joining repair of DNA double-strand breaks (DSB) and strongly potentiates the antitumor effect of ionizing radiation (IR) and topoisomerase II inhibitors. By...
Enregistré dans:
Auteurs principaux: | Eric Haines, Yuki Nishida, Michael I. Carr, Rafael Heinz Montoya, Lauren B. Ostermann, Weiguo Zhang, Frank T. Zenke, Andree Blaukat, Michael Andreeff, Lyubomir T. Vassilev |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/36b7c6a88d6e4d8b9b33159cd731cb9e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Spatiotemporal dynamics of 53BP1 dimer recruitment to a DNA double strand break
par: Jieqiong Lou, et autres
Publié: (2020) -
CHD7 and 53BP1 regulate distinct pathways for the re-ligation of DNA double-strand breaks
par: Magdalena B. Rother, et autres
Publié: (2020) -
DNA single-strand break-induced DNA damage response causes heart failure
par: Tomoaki Higo, et autres
Publié: (2017) -
Hypermutability of damaged single-strand DNA formed at double-strand breaks and uncapped telomeres in yeast Saccharomyces cerevisiae.
par: Yong Yang, et autres
Publié: (2008) -
Senataxin resolves RNA:DNA hybrids forming at DNA double-strand breaks to prevent translocations
par: Sarah Cohen, et autres
Publié: (2018)